Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Belgium Daily Times.
Press releases published on May 27, 2025
Novel Viscoelastic Coagulation Monitor (VCM) Granted FDA Breakthrough Designation for Assessing Preterm Neonates
EIN Presswire
·
May 27, 2025
VCM to be Used to Assess Coagulation Status from Whole Blood of Preterm Neonates Aged 28 or More Weeks, Full Term and Newborns up to Six Months Post-Birth DURHAM, NC, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Entegrion, Inc., a leading developer …
SOLUM Expands Production Capacity and Accelerates Retail Digitalisation Across Europe and North America
EIN Presswire
·
May 27, 2025
LONDON, UNITED KINGDOM, May 27, 2025 /EINPresswire.com/ -- SOLUM, a global leader in electronic shelf labels (ESL) and digital retail solutions, is expanding production capacity and securing key wins across Europe and North America as demand for smart …
Ninjascan.Ai Met L'accent Sur Le Référentiel Général D’amélioration De L’accessibilité
EIN Presswire
·
May 27, 2025
Et Propose Un Outil D'audit Du Web Local Qui Change La Donne SAARBRUCKEN, SAARLAND, GERMANY, May 27, 2025 /EINPresswire.com/ -- Alors que l'application de Le Référentiel Général D’amélioration De L’accessibilité (RGAA) approche à grands pas, le 28 …
Augustine Therapeutics announces first patient dosed in Phase I clinical trial evaluating lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth disease
GlobeNewswire
·
May 27, 2025
AGT-100216 is the first HDAC6 inhibitor from Augustine’s pipeline to enter clinical trials LEUVEN, Belgium – 27 May 2025– Augustine Therapeutics NV (“Augustine” or “the Company”), a biotechnology company focused on developing new therapies for …
Press release: Sequana Medical Secures Additional Convertible Financing of EUR 6.3 Million from SFPIM and Other Existing Shareholders
GlobeNewswire
·
May 27, 2025
Sequana Medical Secures Additional Convertible Financing of EUR 6.3 Million from SFPIM and Other Existing Shareholders Continued strong support from major shareholders alfapump® US commercial launch remains on track for Q3 2025 through specialty …